Form 8-K - Current report:
SEC Accession No. 0000917520-25-000060
Filing Date
2025-06-09
Accepted
2025-06-09 06:30:24
Documents
14
Period of Report
2025-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iart-20250606.htm   iXBRL 8-K 27764
2 EX-4.1 exhibit41amendmentno1seven.htm EX-4.1 161985
  Complete submission text file 0000917520-25-000060.txt   353162

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iart-20250606.xsd EX-101.SCH 2108
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iart-20250606_def.xml EX-101.DEF 14411
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iart-20250606_lab.xml EX-101.LAB 25403
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iart-20250606_pre.xml EX-101.PRE 14986
16 EXTRACTED XBRL INSTANCE DOCUMENT iart-20250606_htm.xml XML 2721
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 251032779
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)